chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 1st dose we got may have been expired.; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (1st dose we got may have been expired.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (1st dose we got may have been expired.). On 23-Jun-2021, EXPIRED PRODUCT ADMINISTERED (1st dose we got may have been expired.) had resolved.            No concomitant medication was reported.  No treatment information was reported.   This case was linked to MOD-2021-234082 (Patient Link).
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received a dose from a vial that was expired; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a dose from a vial that was expired) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a dose from a vial that was expired). On 22-Jun-2021, EXPIRED PRODUCT ADMINISTERED (received a dose from a vial that was expired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.   Reporter stated that the patient have reported any adverse event after getting the vaccine shot. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea, Functional gastrointestinal disorder
Clinical narrative: diarrhea; changed in bowel activity; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and FUNCTIONAL GASTROINTESTINAL DISORDER (changed in bowel activity) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DIARRHOEA (diarrhea) and FUNCTIONAL GASTROINTESTINAL DISORDER (changed in bowel activity). At the time of the report, DIARRHOEA (diarrhea) and FUNCTIONAL GASTROINTESTINAL DISORDER (changed in bowel activity) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site pain
Clinical narrative: covid arm; extremely painful (arm); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (covid arm) and VACCINATION SITE PAIN (extremely painful (arm)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (covid arm) and VACCINATION SITE PAIN (extremely painful (arm)). At the time of the report, VACCINATION COMPLICATION (covid arm) and VACCINATION SITE PAIN (extremely painful (arm)) outcome was unknown. Not Provided          Patient received second dose on March 30th.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Product dose omission issue, SARS-CoV-2 test
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19 after first dose), FATIGUE and PRODUCT DOSE OMISSION ISSUE in an 82-year-old male patient who received mRNA-1273 (MODERNA COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included Stroke (occurred last year). Concomitant products included AMLODIPINE, ATORVASTATIN and METFORMIN for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jun-2021, the patient experienced COVID-19 (Tested positive for COVID-19 after first dose). On an unknown date, the patient experienced FATIGUE (Feeling tired) and PRODUCT DOSE OMISSION ISSUE (Over 42 days from first dose). At the time of the report, COVID-19 (Tested positive for COVID-19 after first dose) and FATIGUE (Feeling tired) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Over 42 days from first dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jun-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: felt sick; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (felt sick) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B212A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, the patient experienced VACCINATION COMPLICATION (felt sick). At the time of the report, VACCINATION COMPLICATION (felt sick) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter   This case was linked to MOD-2021-233047 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: second dose of the Moderna vaccine has been administered 2 weeks after the first one/Vaccine received 2 weeks apart; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of the Moderna vaccine has been administered 2 weeks after the first one/Vaccine received 2 weeks apart) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of the Moderna vaccine has been administered 2 weeks after the first one/Vaccine received 2 weeks apart). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of the Moderna vaccine has been administered 2 weeks after the first one/Vaccine received 2 weeks apart) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow up received on 23-jun-2021 contains No Significant information. Consent Follow up Declined.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Malaise, Myalgia, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of malaise (did not feel well), vomiting (all night until today), myalgia (body aches), pyrexia (fever of 101.3ºF) and terrible headache in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 009C21A) for COVID-19 immunization. No medical history reported. On Jun 22, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 22, 2021, patient experienced malaise (did not feel well), vomiting (all night until today), myalgia (body aches), pyrexia (fever of 101.3ºF) and terrible headache. At the time of the report, malaise (did not feel well), vomiting (all night until today), myalgia (body aches), pyrexia (fever of 101.3ºF) and terrible headache outcome: unknown. Diagnostic results: On Jun 22, 2021, Body temperature: 101.3ºF (inconclusive). No concomitant medication or treatment information provided. This case linked to MOD-2021-233019 (patient link).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of malaise (did not feel well), vomiting (all night until today), myalgia (body aches), pyrexia (fever of 101.3ºF) and terrible headache in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 009C21A) for COVID-19 immunization. No medical history reported. On Jun 22, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 22, 2021, patient experienced malaise (did not feel well), vomiting (all night until today), myalgia (body aches), pyrexia (fever of 101.3ºF) and terrible headache. At the time of the report, malaise (did not feel well), vomiting (all night until today), myalgia (body aches), pyrexia (fever of 101.3ºF) and terrible headache outcome: unknown. Diagnostic results: On Jun 22, 2021, Body temperature: 101.3ºF (inconclusive). No concomitant medication or treatment information provided. This case linked to MOD-2021-233019 (patient link).
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: Red bumps that itch like crazy; Full body rash/they are popping out like popcorn": back, legs, hands, chest, foot, neck; Red bumps that itch like crazy; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Red bumps that itch like crazy), RASH (Full body rash/they are popping out like popcorn": back, legs, hands, chest, foot, neck) and RASH ERYTHEMATOUS (Red bumps that itch like crazy) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (Red bumps that itch like crazy), RASH (Full body rash/they are popping out like popcorn": back, legs, hands, chest, foot, neck) and RASH ERYTHEMATOUS (Red bumps that itch like crazy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at a dose of 1 dosage form. At the time of the report, RASH PRURITIC (Red bumps that itch like crazy), RASH (Full body rash/they are popping out like popcorn": back, legs, hands, chest, foot, neck) and RASH ERYTHEMATOUS (Red bumps that itch like crazy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. Treatment had been treating with  3 different creams none seem to be getting rid of it.. Patient said that Provider's next suggestion is a Kenalog (steroid) shot, but not specified the patient has been taken.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up  received on 29-JUN-2021 and does not contain any new information.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea, Myalgia, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: hot injection site; my injection site became swollen; red injection site; i also developed diarrhea; i had the normal arm pain for 24 hrs; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (i also developed diarrhea), VACCINATION SITE WARMTH (hot injection site), MYALGIA (i had the normal arm pain for 24 hrs), VACCINATION SITE SWELLING (my injection site became swollen) and VACCINATION SITE ERYTHEMA (red injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, the patient experienced MYALGIA (i had the normal arm pain for 24 hrs). On 15-Jun-2021, the patient experienced DIARRHOEA (i also developed diarrhea). On 20-Jun-2021, the patient experienced VACCINATION SITE WARMTH (hot injection site), VACCINATION SITE SWELLING (my injection site became swollen) and VACCINATION SITE ERYTHEMA (red injection site). On 15-Jun-2021, MYALGIA (i had the normal arm pain for 24 hrs) had resolved. At the time of the report, DIARRHOEA (i also developed diarrhea) had not resolved and VACCINATION SITE WARMTH (hot injection site), VACCINATION SITE SWELLING (my injection site became swollen) and VACCINATION SITE ERYTHEMA (red injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  No concomitant medications were reported.   Patient reported no changes in her diet or anything.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: does moderna vaccine cause lymph nodes to swell in your armpit; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (does moderna vaccine cause lymph nodes to swell in your armpit) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (does moderna vaccine cause lymph nodes to swell in your armpit). At the time of the report, LYMPHADENOPATHY (does moderna vaccine cause lymph nodes to swell in your armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment medication was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: I have developed random urticaria; I break out in a rash in random places on a daily basis; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (I have developed random urticaria) and RASH (I break out in a rash in random places on a daily basis) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced URTICARIA (I have developed random urticaria) and RASH (I break out in a rash in random places on a daily basis). At the time of the report, URTICARIA (I have developed random urticaria) and RASH (I break out in a rash in random places on a daily basis) outcome was unknown.            No concomitant and treatment medications were reported.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pyrexia, Retching, Tremor
Clinical narrative: bad headache; Fever/Temperature of 101-102, went up to 105.3/; he was uncontrollably shaking; he almost vomited; he was retching; Temperature went down to 102.5; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (bad headache), PYREXIA (Fever/Temperature of 101-102, went up to 105.3/), TREMOR (he was uncontrollably shaking), VOMITING (he almost vomited) and RETCHING (he was retching) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jun-2021, the patient experienced HEADACHE (bad headache), PYREXIA (Fever/Temperature of 101-102, went up to 105.3/), TREMOR (he was uncontrollably shaking), VOMITING (he almost vomited), RETCHING (he was retching) and PYREXIA (Temperature went down to 102.5). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, HEADACHE (bad headache), PYREXIA (Fever/Temperature of 101-102, went up to 105.3/), TREMOR (he was uncontrollably shaking), VOMITING (he almost vomited), RETCHING (he was retching) and PYREXIA (Temperature went down to 102.5) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jun-2021, Body temperature: 101-102 Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: bad headache; Fever/Temperature of 101-102, went up to 105.3/; he was uncontrollably shaking; he almost vomited; he was retching; Temperature went down to 102.5; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (bad headache), PYREXIA (Fever/Temperature of 101-102, went up to 105.3/), TREMOR (he was uncontrollably shaking), VOMITING (he almost vomited) and RETCHING (he was retching) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jun-2021, the patient experienced HEADACHE (bad headache), PYREXIA (Fever/Temperature of 101-102, went up to 105.3/), TREMOR (he was uncontrollably shaking), VOMITING (he almost vomited), RETCHING (he was retching) and PYREXIA (Temperature went down to 102.5). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, HEADACHE (bad headache), PYREXIA (Fever/Temperature of 101-102, went up to 105.3/), TREMOR (he was uncontrollably shaking), VOMITING (he almost vomited), RETCHING (he was retching) and PYREXIA (Temperature went down to 102.5) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jun-2021, Body temperature: 101-102 Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: I have low grade temp; body ache; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (I have low grade temp) and MYALGIA (body ache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (I have low grade temp) and MYALGIA (body ache). At the time of the report, PYREXIA (I have low grade temp) and MYALGIA (body ache) outcome was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Myalgia, Pyrexia, Tachycardia
Clinical narrative: Tachycardia; Weakness; Body aches; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Tachycardia), ASTHENIA (Weakness), MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 040B21A) for COVID-19 vaccination.     The patient's past medical history included Pre-diabetic. Concomitant products included OMEPRAZOLE, BROMURO DE PINAVERIO and SENNOSIDE A+B (SENOSIDOS AB) for an unknown indication.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced TACHYCARDIA (Tachycardia), ASTHENIA (Weakness), MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg * 2 and ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form. At the time of the report, TACHYCARDIA (Tachycardia), ASTHENIA (Weakness), MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessment
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 72 days since my first shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (72 days since my first shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (72 days since my first shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (72 days since my first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were provided  For mRNA-1273 (Moderna COVID-19 Vaccine), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Aphonia, Cough
Clinical narrative: Losing your voice; Getting a cough; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of APHONIA (Losing your voice) and COUGH (Getting a cough) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced APHONIA (Losing your voice) and COUGH (Getting a cough). At the time of the report, APHONIA (Losing your voice) and COUGH (Getting a cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Treatment medication was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Illness, Myalgia, Oral candidiasis
Clinical narrative: Was really sick; White thrush on my tongue, down my throat (after second shot); Muscle pain after second shot; chills after second shot; Headache after second shot; Fever after second shot; This spontaneous case was reported by a consumer and describes the occurrence of ORAL CANDIDIASIS (White thrush on my tongue, down my throat (after second shot) ), ILLNESS (Was really sick), MYALGIA (Muscle pain after second shot ), CHILLS (chills after second shot ) and HEADACHE (Headache after second shot ) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, the patient experienced MYALGIA (Muscle pain after second shot ), CHILLS (chills after second shot ), HEADACHE (Headache after second shot ) and PYREXIA (Fever after second shot  ). On 23-Jun-2021, the patient experienced ORAL CANDIDIASIS (White thrush on my tongue, down my throat (after second shot) ). On an unknown date, the patient experienced ILLNESS (Was really sick). At the time of the report, ORAL CANDIDIASIS (White thrush on my tongue, down my throat (after second shot) ), ILLNESS (Was really sick), MYALGIA (Muscle pain after second shot ), CHILLS (chills after second shot ), HEADACHE (Headache after second shot ) and PYREXIA (Fever after second shot  ) outcome was unknown.            No concomitant medication were reported.  No treatment information was reported
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Was really sick; White thrush on my tongue, down my throat (after second shot); Muscle pain after second shot; chills after second shot; Headache after second shot; Fever after second shot; This spontaneous case was reported by a consumer and describes the occurrence of ORAL CANDIDIASIS (White thrush on my tongue, down my throat (after second shot) ), ILLNESS (Was really sick), MYALGIA (Muscle pain after second shot ), CHILLS (chills after second shot ) and HEADACHE (Headache after second shot ) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, the patient experienced MYALGIA (Muscle pain after second shot ), CHILLS (chills after second shot ), HEADACHE (Headache after second shot ) and PYREXIA (Fever after second shot  ). On 23-Jun-2021, the patient experienced ORAL CANDIDIASIS (White thrush on my tongue, down my throat (after second shot) ). On an unknown date, the patient experienced ILLNESS (Was really sick). At the time of the report, ORAL CANDIDIASIS (White thrush on my tongue, down my throat (after second shot) ), ILLNESS (Was really sick), MYALGIA (Muscle pain after second shot ), CHILLS (chills after second shot ), HEADACHE (Headache after second shot ) and PYREXIA (Fever after second shot  ) outcome was unknown.            No concomitant medication were reported.  No treatment information was reported
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Chills, Dyspnoea, Headache
Clinical narrative: Weakness; Tachycardia; "Looks sick"; shortness of breath; Cold sores on lips; difficulty hearing from both ears; Anxiety; Body aches; "Stronger fever"; Headache; Chills; This spontaneous case was reported by a non-health professional and describes the occurrence of ASTHENIA (Weakness), TACHYCARDIA (Tachycardia), ILLNESS ("Looks sick"), DYSPNOEA (shortness of breath) and ORAL HERPES (Cold sores on lips) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Prediabetes. Concomitant products included OMEPRAZOLE, PINAVERIUM BROMIDE and SENNA GLYCOSIDES for an unknown indication.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced ASTHENIA (Weakness), TACHYCARDIA (Tachycardia), ILLNESS ("Looks sick"), DYSPNOEA (shortness of breath), ORAL HERPES (Cold sores on lips), HYPOACUSIS (difficulty hearing from both ears), ANXIETY (Anxiety), MYALGIA (Body aches), PYREXIA ("Stronger fever"), HEADACHE (Headache) and CHILLS (Chills). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Headache, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weakness), ORAL HERPES (Cold sores on lips), MYALGIA (Body aches) and PYREXIA ("Stronger fever") outcome was unknown and TACHYCARDIA (Tachycardia), ILLNESS ("Looks sick"), DYSPNOEA (shortness of breath), HYPOACUSIS (difficulty hearing from both ears), ANXIETY (Anxiety), HEADACHE (Headache) and CHILLS (Chills) had not resolved.            No other treatment information was reported.   This case was linked to MOD-2021-233164 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoacusis, Illness, Myalgia, Oral herpes, Pyrexia
Clinical narrative: Weakness; Tachycardia; "Looks sick"; shortness of breath; Cold sores on lips; difficulty hearing from both ears; Anxiety; Body aches; "Stronger fever"; Headache; Chills; This spontaneous case was reported by a non-health professional and describes the occurrence of ASTHENIA (Weakness), TACHYCARDIA (Tachycardia), ILLNESS ("Looks sick"), DYSPNOEA (shortness of breath) and ORAL HERPES (Cold sores on lips) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Prediabetes. Concomitant products included OMEPRAZOLE, PINAVERIUM BROMIDE and SENNA GLYCOSIDES for an unknown indication.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced ASTHENIA (Weakness), TACHYCARDIA (Tachycardia), ILLNESS ("Looks sick"), DYSPNOEA (shortness of breath), ORAL HERPES (Cold sores on lips), HYPOACUSIS (difficulty hearing from both ears), ANXIETY (Anxiety), MYALGIA (Body aches), PYREXIA ("Stronger fever"), HEADACHE (Headache) and CHILLS (Chills). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Headache, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weakness), ORAL HERPES (Cold sores on lips), MYALGIA (Body aches) and PYREXIA ("Stronger fever") outcome was unknown and TACHYCARDIA (Tachycardia), ILLNESS ("Looks sick"), DYSPNOEA (shortness of breath), HYPOACUSIS (difficulty hearing from both ears), ANXIETY (Anxiety), HEADACHE (Headache) and CHILLS (Chills) had not resolved.            No other treatment information was reported.   This case was linked to MOD-2021-233164 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Weakness; Tachycardia; "Looks sick"; shortness of breath; Cold sores on lips; difficulty hearing from both ears; Anxiety; Body aches; "Stronger fever"; Headache; Chills; This spontaneous case was reported by a non-health professional and describes the occurrence of ASTHENIA (Weakness), TACHYCARDIA (Tachycardia), ILLNESS ("Looks sick"), DYSPNOEA (shortness of breath) and ORAL HERPES (Cold sores on lips) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Prediabetes. Concomitant products included OMEPRAZOLE, PINAVERIUM BROMIDE and SENNA GLYCOSIDES for an unknown indication.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced ASTHENIA (Weakness), TACHYCARDIA (Tachycardia), ILLNESS ("Looks sick"), DYSPNOEA (shortness of breath), ORAL HERPES (Cold sores on lips), HYPOACUSIS (difficulty hearing from both ears), ANXIETY (Anxiety), MYALGIA (Body aches), PYREXIA ("Stronger fever"), HEADACHE (Headache) and CHILLS (Chills). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Headache, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weakness), ORAL HERPES (Cold sores on lips), MYALGIA (Body aches) and PYREXIA ("Stronger fever") outcome was unknown and TACHYCARDIA (Tachycardia), ILLNESS ("Looks sick"), DYSPNOEA (shortness of breath), HYPOACUSIS (difficulty hearing from both ears), ANXIETY (Anxiety), HEADACHE (Headache) and CHILLS (Chills) had not resolved.            No other treatment information was reported.   This case was linked to MOD-2021-233164 (Patient Link).
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: left arm sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (left arm sore) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, the patient experienced MYALGIA (left arm sore). At the time of the report, MYALGIA (left arm sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: answered yes, to experiencing side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (answered yes, to experiencing side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (answered yes, to experiencing side effects). At the time of the report, VACCINATION COMPLICATION (answered yes, to experiencing side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Anaemia, Confusional state
Clinical narrative: Mild confusion; Anaemia; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Mild confusion) and ANAEMIA (Anaemia) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (Mild confusion) and ANAEMIA (Anaemia). At the time of the report, CONFUSIONAL STATE (Mild confusion) and ANAEMIA (Anaemia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned. No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Additional information received on 29 June 2021 Included event Anemia and primary reporter contact details updated.
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Eructation, Pain in extremity
Clinical narrative: bit of shortness of breath; burping a lot at night; finger hurt; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (bit of shortness of breath), ERUCTATION (burping a lot at night) and PAIN IN EXTREMITY (finger hurt) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (bit of shortness of breath), ERUCTATION (burping a lot at night) and PAIN IN EXTREMITY (finger hurt). At the time of the report, DYSPNOEA (bit of shortness of breath), ERUCTATION (burping a lot at night) and PAIN IN EXTREMITY (finger hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia, Skin test negative
Clinical narrative: Tired; Headache; febrile; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (Tired), HEADACHE (Headache) and PYREXIA (febrile) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to chemicals (methyl acrylates). Concomitant products included CANDESARTAN for Blood pressure, SIMVASTATIN for Hyperlipidemia, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Nasal allergy, CALCIUM, ASCORBIC ACID (VIT C) and GLUCOSAMINE for an unknown indication.   On 30-Dec-2020 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Tired), HEADACHE (Headache) and PYREXIA (febrile). At the time of the report, FATIGUE (Tired), HEADACHE (Headache) and PYREXIA (febrile) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Skin test negative: negative (Negative) Patch testing came negative and physician concluded it could have been an Arthus reaction.         No current illness, historical data was reported by patient.  Treatment medication was not reported by patient.  Patient went to immunologist for patch testing to ensure she was not allergic to an ingredient of vaccine in order to schedule the second dose.    This case was linked to MOD-2021-003821 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Body temperature, Illness, Insomnia
Clinical narrative: became very sick; diffuse/transient joint pain; Fever of 101 degrees Fahrenheit; inability to sleep/insomnia; GI symptoms; More than 42 days from first dose; swelling of entire left arm; This spontaneous case was reported by a physician and describes the occurrence of INSOMNIA (inability to sleep/insomnia), PERIPHERAL SWELLING (swelling of entire left arm), ABDOMINAL DISCOMFORT (GI symptoms), PRODUCT DOSE OMISSION ISSUE (More than 42 days from first dose) and ILLNESS (became very sick) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0411.20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hormone replacement therapy. Concurrent medical conditions included Autoimmune disorder (Autoimmune/hyperimmune disorder), Lyme disease (Chronic) and Thyroid disorder NOS. Concomitant products included ESTRADIOL (ESTROGEN) for Hormone replacement therapy, LEVOTHYROXINE for Thyroid disorder NOS, ATENOLOL for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PERIPHERAL SWELLING (swelling of entire left arm). On 02-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 42 days from first dose). On 03-Mar-2021, the patient experienced INSOMNIA (inability to sleep/insomnia), ABDOMINAL DISCOMFORT (GI symptoms) and PYREXIA (Fever of 101 degrees Fahrenheit). On 09-Mar-2021, the patient experienced ARTHRALGIA (diffuse/transient joint pain). On an unknown date, the patient experienced ILLNESS (became very sick). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 02-Mar-2021, PRODUCT DOSE OMISSION ISSUE (More than 42 days from first dose) had resolved. On 04-Mar-2021, PYREXIA (Fever of 101 degrees Fahrenheit) had resolved. On 07-Mar-2021, PERIPHERAL SWELLING (swelling of entire left arm) had resolved. On 17-Mar-2021, ABDOMINAL DISCOMFORT (GI symptoms) had resolved. On 10-Jun-2021, INSOMNIA (inability to sleep/insomnia) had resolved. At the time of the report, ILLNESS (became very sick) and ARTHRALGIA (diffuse/transient joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (abnormal) 101 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Non significant follow up received. Patient is querying mailing address to print out the form and mail it as she doesn't have a scan or fax available. On 21-Jul-2021: Follow up received. It provides no new information.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Pyrexia, Vaccination site swelling
Clinical narrative: became very sick; diffuse/transient joint pain; Fever of 101 degrees Fahrenheit; inability to sleep/insomnia; GI symptoms; More than 42 days from first dose; swelling of entire left arm; This spontaneous case was reported by a physician and describes the occurrence of INSOMNIA (inability to sleep/insomnia), PERIPHERAL SWELLING (swelling of entire left arm), ABDOMINAL DISCOMFORT (GI symptoms), PRODUCT DOSE OMISSION ISSUE (More than 42 days from first dose) and ILLNESS (became very sick) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0411.20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hormone replacement therapy. Concurrent medical conditions included Autoimmune disorder (Autoimmune/hyperimmune disorder), Lyme disease (Chronic) and Thyroid disorder NOS. Concomitant products included ESTRADIOL (ESTROGEN) for Hormone replacement therapy, LEVOTHYROXINE for Thyroid disorder NOS, ATENOLOL for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PERIPHERAL SWELLING (swelling of entire left arm). On 02-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 42 days from first dose). On 03-Mar-2021, the patient experienced INSOMNIA (inability to sleep/insomnia), ABDOMINAL DISCOMFORT (GI symptoms) and PYREXIA (Fever of 101 degrees Fahrenheit). On 09-Mar-2021, the patient experienced ARTHRALGIA (diffuse/transient joint pain). On an unknown date, the patient experienced ILLNESS (became very sick). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 02-Mar-2021, PRODUCT DOSE OMISSION ISSUE (More than 42 days from first dose) had resolved. On 04-Mar-2021, PYREXIA (Fever of 101 degrees Fahrenheit) had resolved. On 07-Mar-2021, PERIPHERAL SWELLING (swelling of entire left arm) had resolved. On 17-Mar-2021, ABDOMINAL DISCOMFORT (GI symptoms) had resolved. On 10-Jun-2021, INSOMNIA (inability to sleep/insomnia) had resolved. At the time of the report, ILLNESS (became very sick) and ARTHRALGIA (diffuse/transient joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (abnormal) 101 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Non significant follow up received. Patient is querying mailing address to print out the form and mail it as she doesn't have a scan or fax available. On 21-Jul-2021: Follow up received. It provides no new information.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: vaccinated on May 8 with the first dose , I then left the country and will not be back until July 19th; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (vaccinated on May 8 with the first dose , I then left the country and will not be back until July 19th) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (vaccinated on May 8 with the first dose , I then left the country and will not be back until July 19th). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (vaccinated on May 8 with the first dose , I then left the country and will not be back until July 19th) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.